Multimodality Imaging in Cranial Giant Cell Arteritis: First Experience with High-Resolution T1-Weighted 3D Black Blood without Contrast Enhancement Magnetic Resonance Imaging
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Multimodality Imaging in Cranial Giant Cell Arteritis : First Experience with High-Resolution T1-Weighted 3D Black Blood without Contrast Enhancement Magnetic Resonance Imaging. / Brittain, Jane Maestri; Hansen, Michael Stormly; Carlsen, Jonathan Frederik; Brandt, Andreas Hjelm; Terslev, Lene; Jensen, Mads Radmer; Lindberg, Ulrich; Larsson, Henrik Bo Wiberg; Heegaard, Steffen; Døhn, Uffe Møller; Klefter, Oliver Niels; Wiencke, Anne Katrine; Subhi, Yousif; Hamann, Steffen; Haddock, Bryan.
In: Diagnostics, Vol. 14, No. 1, 81, 2024.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Multimodality Imaging in Cranial Giant Cell Arteritis
T2 - First Experience with High-Resolution T1-Weighted 3D Black Blood without Contrast Enhancement Magnetic Resonance Imaging
AU - Brittain, Jane Maestri
AU - Hansen, Michael Stormly
AU - Carlsen, Jonathan Frederik
AU - Brandt, Andreas Hjelm
AU - Terslev, Lene
AU - Jensen, Mads Radmer
AU - Lindberg, Ulrich
AU - Larsson, Henrik Bo Wiberg
AU - Heegaard, Steffen
AU - Døhn, Uffe Møller
AU - Klefter, Oliver Niels
AU - Wiencke, Anne Katrine
AU - Subhi, Yousif
AU - Hamann, Steffen
AU - Haddock, Bryan
N1 - Publisher Copyright: © 2023 by the authors.
PY - 2024
Y1 - 2024
N2 - In order to support or refute the clinical suspicion of cranial giant cell arteritis (GCA), a supplemental imaging modality is often required. High-resolution black blood Magnetic Resonance Imaging (BB MRI) techniques with contrast enhancement can visualize artery wall inflammation in GCA. We compared findings on BB MRI without contrast enhancement with findings on 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/low-dose computed tomography (2-[18F]FDG PET/CT) in ten patients suspected of having GCA and in five control subjects who had a 2-[18F]FDG PET/CT performed as a routine control for malignant melanoma. BB MRI was consistent with 2-[18F]FDG PET/CT in 10 out of 10 cases in the group with suspected GCA. In four out of five cases in the control group, the BB MRI was consistent with 2-[18F]FDG PET/CT. In this small population, BB MRI without contrast enhancement shows promising performance in the diagnosis of GCA, and might be an applicable imaging modality in patients.
AB - In order to support or refute the clinical suspicion of cranial giant cell arteritis (GCA), a supplemental imaging modality is often required. High-resolution black blood Magnetic Resonance Imaging (BB MRI) techniques with contrast enhancement can visualize artery wall inflammation in GCA. We compared findings on BB MRI without contrast enhancement with findings on 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/low-dose computed tomography (2-[18F]FDG PET/CT) in ten patients suspected of having GCA and in five control subjects who had a 2-[18F]FDG PET/CT performed as a routine control for malignant melanoma. BB MRI was consistent with 2-[18F]FDG PET/CT in 10 out of 10 cases in the group with suspected GCA. In four out of five cases in the control group, the BB MRI was consistent with 2-[18F]FDG PET/CT. In this small population, BB MRI without contrast enhancement shows promising performance in the diagnosis of GCA, and might be an applicable imaging modality in patients.
KW - 3D black blood
KW - FDG PET/CT
KW - giant cell arteritis
KW - MRI
KW - multimodality imaging
KW - non-contrast enhancement
KW - temporal artery biopsy
KW - vascular ultrasound
U2 - 10.3390/diagnostics14010081
DO - 10.3390/diagnostics14010081
M3 - Journal article
C2 - 38201390
AN - SCOPUS:85181923981
VL - 14
JO - Diagnostics
JF - Diagnostics
SN - 2075-4418
IS - 1
M1 - 81
ER -
ID: 379712158